Article originally published by The Grainger College of Engineering / April 23, 2026
A biology-based technology company founded by Illinois Grainger alums will use recent funding to support commercial delivery of AI-based precision medicine tools.
Bobby Reddy, Jr. knows a thing or two about maps.
Reddy’s company, Prenosis — co-founded with Illinois Grainger Engineering Professor and current Dean Rashid Bashir — develops AI diagnostic tools for precision medicine in acute care by mapping patients’ unique biological profiles. Prenosis announced in January the completion of its $20 million Series A Financing Round and a $20 million contract with the Biomedical Advanced Research and Development Authority (BARDA). This combined $40 million in funding will advance the development of Prenosis’ AI diagnostic and therapeutic products, improving patient outcomes for serious yet underfunded conditions like sepsis. But before Reddy (‘12, Ph.D., electrical and computer engineering) and his company were mapping biological profiles, he was mapping something else—hospital care for critical conditions.
Read the full article >




